A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes

Wieneke A. Buikhuisen; Marion Scharpfenecker; Arjan W. Griffioen; Catharina M. Korse; Harm van Tinteren; Paul Baas

doi:10.1016/j.jtho.2016.01.014

A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes

Wieneke A. Buikhuisen, Marion Scharpfenecker, Arjan W. Griffioen, Catharina M. Korse, Harm van Tinteren, Paul Baas

Medical oncology laboratory

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	758-768
Journal	Journal of Thoracic Oncology
Volume	11
Issue number	5
DOIs	https://doi.org/10.1016/j.jtho.2016.01.014
Publication status	Published - May 2016

Access to Document

10.1016/j.jtho.2016.01.014

Cite this

Buikhuisen, W. A., Scharpfenecker, M., Griffioen, A. W., Korse, C. M., van Tinteren, H., & Baas, P. (2016). A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes. Journal of Thoracic Oncology, 11(5), 758-768. https://doi.org/10.1016/j.jtho.2016.01.014

Buikhuisen, Wieneke A. ; Scharpfenecker, Marion ; Griffioen, Arjan W. ; Korse, Catharina M. ; van Tinteren, Harm ; Baas, Paul. / A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes. In: Journal of Thoracic Oncology. 2016 ; Vol. 11, No. 5. pp. 758-768.

@article{9bef9206d8a6458e92824ca31827c919,

title = "A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes",

keywords = "Mesothelioma, Axitinib, VEGF, Angiogenesis, Phase II, Translational research",

author = "Buikhuisen, {Wieneke A.} and Marion Scharpfenecker and Griffioen, {Arjan W.} and Korse, {Catharina M.} and {van Tinteren}, Harm and Paul Baas",

year = "2016",

month = "5",

doi = "10.1016/j.jtho.2016.01.014",

language = "English",

volume = "11",

pages = "758--768",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "5",

}

Buikhuisen, WA, Scharpfenecker, M, Griffioen, AW, Korse, CM, van Tinteren, H & Baas, P 2016, 'A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes', Journal of Thoracic Oncology, vol. 11, no. 5, pp. 758-768. https://doi.org/10.1016/j.jtho.2016.01.014

A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes. / Buikhuisen, Wieneke A.; Scharpfenecker, Marion; Griffioen, Arjan W.; Korse, Catharina M.; van Tinteren, Harm; Baas, Paul.

In: Journal of Thoracic Oncology, Vol. 11, No. 5, 05.2016, p. 758-768.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes

AU - Buikhuisen, Wieneke A.

AU - Scharpfenecker, Marion

AU - Griffioen, Arjan W.

AU - Korse, Catharina M.

AU - van Tinteren, Harm

AU - Baas, Paul

PY - 2016/5

Y1 - 2016/5

KW - Mesothelioma

KW - Axitinib

KW - VEGF

KW - Angiogenesis

KW - Phase II

KW - Translational research

U2 - 10.1016/j.jtho.2016.01.014

DO - 10.1016/j.jtho.2016.01.014

M3 - Article

C2 - 26845191

VL - 11

SP - 758

EP - 768

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 5

ER -